NextCure (NXTC) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

NextCure (NXTC) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

NextCure

· NXTC

Dashboard

Financials

Ratios

Valuation

Statistics

22.93 M

+3.39%

General

Market Cap: $22.18M
Enterprise Value: $7.59M
Shares Outstanding: 4,070,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -188.98%
ROE: -175.46%
ROIC: -259.91%
Current Ratio: 3.47
Debt-to-Equity: 0.35
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 1.53
EV/EBITDA: -0.18

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $43.62M
Operating Income: -$43.9M
Net Profit: -$42.75M

Balance Sheet

Cash and Equivalents: $15.26M
Working Capital: $15.84M
Total Assets: $22.62M
Net Debt: -$10.97M
Total Liabilities: $10.47M
Total Equity: $12.15M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$36.98M
Cash Flow from Investing: $25.79M
Cash Flow from Financing: $21.56M
Free Cash Flow: -$36.98M
Capital Expenditures: $0